Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7201
Voyager Therapeutics
VYGR
$203M
| $798K | ﹤0.01% |
103,513
-58,404
| -36% | -$464K |
|
7202
PUT
Alkermes
ALKS
$8.3B
| $798K | ﹤0.01% |
28,300
-2,550,500
| -99% | -$69.5M |
|
7203
PUT
JELD-WEN Holding
JELD
$160M
| $798K | ﹤0.01% |
63,000
-1,000
| -2% | -$12.4K |
|
7204
CALL
Andersons Inc
ANDE
$2.34B
| $797K | ﹤0.01% |
19,300
+2,800
| +17% | +$111K |
|
|
AKYA
7205
DELISTED
Akoya BioSciences
AKYA
| $797K | ﹤0.01% |
97,442
-41,787
| -30% | -$437K |
|
7206
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$301M
| $797K | ﹤0.01% |
+27,542
| New | +$789K |
|
7207
CALL
RPC Inc
RES
$1.4B
| $797K | ﹤0.01% |
103,600
+31,900
| +44% | +$284K |
|
7208
Genesco
GCO
$387M
| $796K | ﹤0.01% |
21,584
-53,320
| -71% | -$2.34M |
|
7209
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$88.5M
| $796K | ﹤0.01% |
12,589
-18,207
| -59% | -$1.23M |
|
7210
Innovator Growth-100 Power Buffer ETF October
NOCT
$228M
| $795K | ﹤0.01% |
+20,311
| New | +$760K |
|
7211
CALL
Bionano Genomics
BNGO
$13.9M
| $795K | ﹤0.01% |
1,193
-318
| -21% | -$282K |
|
7212
CALL
UFP Industries
UFPI
$4.81B
| $795K | ﹤0.01% |
10,000
-1,700
| -15% | -$145K |
|
7213
PUT
Energy Fuels
UUUU
$3.52B
| $795K | ﹤0.01% |
142,400
-10,300
| -7% | -$66.7K |
|
|
CMBT
7214
PUT
CMB.TECH NV
CMBT
$5.08B
| $794K | ﹤0.01% |
47,300
+23,400
| +98% | +$389K |
|
7215
PUT
Cathay General Bancorp
CATY
$4.28B
| $794K | ﹤0.01% |
23,000
+19,800
| +619% | +$813K |
|
7216
Mercury Systems
MRCY
$6.3B
| $794K | ﹤0.01% |
15,530
-10,450
| -40% | -$528K |
|
|
NOVA
7217
DELISTED
Sunnova Energy
NOVA
| $793K | ﹤0.01% |
50,762
-772,795
| -94% | -$13.5M |
|
7218
PUT
America's Car Mart
CRMT
$25.6M
| $792K | ﹤0.01% |
10,000
-200
| -2% | -$16.3K |
|
7219
CALL
Aldeyra Therapeutics
ALDX
$93.5M
| $791K | ﹤0.01% |
79,700
+23,100
| +41% | +$163K |
|
7220
Invesco S&P SmallCap Financials ETF
PSCF
$27.5M
| $790K | ﹤0.01% |
18,223
+6,990
| +62% | +$340K |
|
7221
Dimensional International Small Cap ETF
DFIS
$5.85B
| $790K | ﹤0.01% |
+34,346
| New | +$785K |
|
7222
PUT
Eldorado Gold
EGO
$10.1B
| $789K | ﹤0.01% |
76,200
-11,400
| -13% | -$106K |
|
7223
Limbach Holdings
LMB
$515M
| $789K | ﹤0.01% |
45,597
+36,296
| +390% | +$493K |
|
|
CIZ
7224
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $789K | ﹤0.01% |
+25,359
| New | +$793K |
|
7225
PUT
Costamare
CMRE
$1.8B
| $789K | ﹤0.01% |
83,800
-2,500
| -3% | -$24.7K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.